Atlas Trials

PD-L1-expressing Regulatory T Cells in Localized Prostate Cancer Patients Undergoing Iodine-125 Permanent Brachytherapy

Clinical trial NCT04369508 · UNKNOWN

Trial details

NCT number
NCT04369508
Sponsor
Xuanwu Hospital, Beijing
Status
UNKNOWN
Study type
OBSERVATIONAL
Prostate Cancer
Start date
2020-07-01
Primary completion
2021-12-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.